Evotec SE (EVO) Net Income Growth (1y) (2010 - 2026)
Powered by 
Analysis
Evotec SE (EVO) Net Income Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | -9.74% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 34.46% |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | -101.44% |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | -31.05% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 96.48% |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 22.54% |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 63.65% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | -64.34% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -329.79% |
| Dec 31, 2025 | -100.04% |
| Sep 30, 2025 | -15.72% |
| Jun 30, 2025 | 51.86% |
| Mar 31, 2025 | -47.90% |
| Dec 31, 2024 | 132.07% |
| Jun 30, 2024 | -119.73% |
| Mar 31, 2024 | -250.55% |
| Dec 31, 2023 | -49.54% |
| Jun 30, 2023 | -56.07% |
| Mar 31, 2023 | 118.15% |
| Dec 31, 2022 | -27.29% |
| Sep 30, 2022 | 58.96% |
| Jun 30, 2022 | -141.25% |
| Mar 31, 2022 | -229.31% |
| Dec 31, 2021 | 613.11% |
| Sep 30, 2021 | -91.23% |
| Dec 31, 2020 | -53.96% |
| Jun 30, 2010 | 100.17% |
| Mar 31, 2010 | -100.01% |